Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|March 23, 2020
Unraveling a new player in multiple sclerosis pathogenesis: The RNA-binding protein HuRCristiana Pistono, Maria Cristina Monti, Nicoletta Marchesi, et al.
Healthcare (Basel, Switzerland)|June 13, 2025
Capturing Information About Multiple Sclerosis Comorbidity Using Clinical Interviews and Administrative Records: Do the Data Sources Agree?Michela Ponzio, Maria Cristina Monti, Paola Borrelli, et al.
Muscle & Nerve|May 25, 2021
COVID-19 in patients with myasthenia gravis: Epidemiology and disease coursePietro Businaro, Gloria Vaghi, Enrico Marchioni, et al.
Journal of Neurology|March 27, 2024
Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS scoreGiulia Mallucci, Ottavia Eleonora Ferraro, Maria Trojano, et al.
Journal of Neuroinflammation|November 7, 2020
Air pollution as a contributor to the inflammatory activity of multiple sclerosisAndrea Cortese, Luca Lova, Patrizia Comoli, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 19, 2025
European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2024
Neurostatus-SMARTCARE clinical trial: Enabling health care professionals to assess EDSS for decentralized trials in multiple sclerosisGiulia Mallucci, Andrea Zimmer, Nikolaos Sfikas, et al.
Journal of Neurology|June 28, 2018
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, P Annovazzi, S Miante, et al.
Journal of Neurology|July 6, 2020
Cell-based assays for the detection of MOG antibodies: a comparative studyMatteo Gastaldi, Silvia Scaranzin, Sven Jarius, et al.
Pageof 5